Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
4 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
12 | 1.5 | 8.98203592814 | 16.7 | 19 | 16.1 | 24558 | 17.3579957 | CS |
26 | 2.3 | 14.465408805 | 15.9 | 19 | 12.501 | 102856 | 15.10252194 | CS |
52 | 4.5 | 32.8467153285 | 13.7 | 19.3 | 12.501 | 234801 | 16.07271182 | CS |
156 | -62 | -77.3067331671 | 80.2 | 112.95 | 9.801 | 190422 | 29.66602299 | CS |
260 | -134.8 | -88.1045751634 | 153 | 168.3 | 9.801 | 167981 | 35.70991727 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.